Evidence map›Paper›PMID 36325569›Full record

ArticleFrontiers in plant science2022

Integrative quantitative and qualitative analysis for the quality evaluation and monitoring of Danshen medicines from different sources using HPLC-DAD and NIR combined with chemometrics.

Qing Li, Luming Qi, Kui Zhao, Wang Ke, Tingting Li, Lina Xia

Abstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Research on Geographical Origin Traceability ofPlants (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Article
  9. Exploration of biophoton characteristics of freshFrontiers in plant science · 2025
    Article
  10. Frontiers in pharmacology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Research progress of sea buckthorn (Frontiers in cardiovascular medicine · 2024
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing LiSchool of Chemistry, Biology and Environment, Yuxi Normal University, Yuxi, China.
Luming QiSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Kui ZhaoCollege of Materials Science and Engineering, Southwest Forestry University, Kunming, China.
Wang KeSchool of Big Data and Artificial Intelligence, Chengdu Technological University, Chengdu, China.
Tingting LiChengdu Institute for Food and Drug Control, Chengdu, China.
Lina XiaSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The root and rhizome of

Indexed as

chemometric modelsHPLC-DADNIRquality evaluation and monitoringSalvia medicines

Identifiers

PMID36325569
PMCPMC9618615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.